DMT — Small Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Small Pharma, fiscal year end - February 28th, CAD millions except per share, conversion factor applied.

	2020 February 28th	R2021 February 28th	2022 February 28th	2023 February 28th
Period Length:	—	—	—	—
Source:	ARS	Interim Report	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.564	5.78	40.7	18.5
Net Total Accounts Receivable
Net Total Receivables	0.219	0.476	1.21	0.8
Prepaid Expenses
Total Current Assets	0.786	6.52	43	20.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.003	0.072	0.062	0.66
Other Long Term Assets
Total Assets	0.789	6.59	45.6	21
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.079	12.4	4.5	3.52
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	0.079	12.4	4.5	3.83
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.71	-5.77	41.1	17.2
Total Liabilities & Shareholders' Equity	0.789	6.59	45.6	21
Total Common Shares Outstanding